These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20307878)

  • 1. Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcome.
    Mann JS; Engmann L; Benadiva CA; Nulsen JC
    Fertil Steril; 2010 Nov; 94(6):2427-9. PubMed ID: 20307878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA; El Din RE
    Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide.
    Shastri SM; Barbieri E; Kligman I; Schoyer KD; Davis OK; Rosenwaks Z
    Fertil Steril; 2011 Feb; 95(2):592-5. PubMed ID: 21074154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders--an observational pilot study.
    Mitri F; Behan LA; Murphy CA; Hershko-Klement A; Casper RF; Bentov Y
    Fertil Steril; 2016 Jan; 105(1):100-5.e1-6. PubMed ID: 26496380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program.
    Toth TL; Awwad JT; Veeck LL; Jones HW; Muasher SJ
    J Reprod Med; 1996 May; 41(5):321-6. PubMed ID: 8725756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies.
    Kovacs P; Sajgo A; Kaali SG; Pal L
    Reprod Sci; 2012 Jul; 19(7):718-24. PubMed ID: 22378863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
    Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
    Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization.
    Keltz MD; Gera PS; Skorupski J; Stein DE
    Fertil Steril; 2007 Aug; 88(2):350-3. PubMed ID: 17693328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
    Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
    Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in long luteal protocol affects the number of days of stimulation: evolution of an assisted reproductive technology practice.
    Palmer CB; Forstein DA; Higdon HL; Boone WR
    J Reprod Med; 2011; 56(7-8):308-12. PubMed ID: 21838160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization.
    Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J
    Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld.
    Erman Akar M; Oktay K
    Arch Gynecol Obstet; 2009 Nov; 280(5):761-5. PubMed ID: 19255769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.